- Home
- TB
TB
What a year! 19 facts about what the world looked like when Johnson & Johnson went public
When the company was first listed on the New York Stock Exchange in 1944, the world was a very different place. Case in point: A quart of milk cost 15 cents!
Why Africa is a hot spot for healthcare innovation
As the Next Einstein Forum Global Gathering kicks off in Rwanda this week, we look at how Johnson & Johnson is helping nurture scientific progress across the continent.
Breath for life: The Johnson & Johnson program that’s helping eradicate tuberculosis in Vietnam
In just two years, a unique collaboration has had an unprecedented impact in the fight against the national epidemic. In honor of World TB Day on March 24, we traveled to one of its most affected provinces to report on the project’s remarkable results.
Meet the Johnson & Johnson Scientist Who’s Helping to Fight Tropical Diseases in His Homeland
Two decades after leaving India, Anil Koul has returned to helm its Institute of Microbial Technology. For Dengue Awareness Month, we caught up with him to learn how he’s hoping to combat this tropical scourge and another disease that kills over a million worldwide.
Johnson & Johnson secures a top spot on the 2016 Access to Medicine Index
The index looks at companies that do the best job of providing access to medications in developing countries. Johnson & Johnson ranked #2—and here’s why.
Johnson & Johnson launches a new global public health strategy in Africa
Jaak Peeters discusses the thinking behind the initiative and how the organization will work in partnership with local governments and NGOs.
The battle to end TB
In honor of World TB Day, we take a look at the work being done in South Africa, Vietnam and India to stop tuberculosis in its tracks.